Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (FY)Dec 31, 2024 | (Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Developing and for sale properties | -20.12%643M | -12.15%730M | -1.95%805M | -0.24%831M | -6.70%821M | -11.57%833M | -6.58%880M | -4.56%942M | -8.63%942M | -8.61%987M |
| Accounts receivable | -14.69%1.52B | 15.50%1.86B | 5.00%1.78B | 9.43%1.61B | 35.59%1.7B | 6.04%1.47B | 7.37%1.25B | -11.01%1.39B | -7.75%1.17B | 23.58%1.56B |
| Related party payments receivable | -7.62%97M | -24.79%88M | 7.14%105M | 36.05%117M | -10.91%98M | -32.81%86M | -6.78%110M | 47.13%128M | 59.46%118M | -25.64%87M |
| Withholding and tax receivable | -58.33%5M | -42.86%8M | -14.29%12M | 16.67%14M | --14M | 200.00%12M | ---- | -73.33%4M | --15M | --15M |
| Cash and equivalents | -32.69%562M | 57.12%1.03B | 24.81%835M | -39.87%653M | -50.07%669M | -3.64%1.09B | 22.49%1.34B | 2.36%1.13B | 3.31%1.09B | -18.69%1.1B |
| Secured deposit | 0.31%326M | -2.59%338M | -2.40%325M | -4.93%347M | -10.48%333M | -5.93%365M | 0.81%372M | 1.57%388M | 49.39%369M | 250.46%382M |
| Special items of current assets | ---- | ---- | 0.00%7M | 16.67%7M | --7M | --6M | ---- | ---- | ---- | ---- |
| Total current assets | -16.67%4.3B | 8.73%5.35B | 14.75%5.16B | 6.27%4.92B | 0.02%4.5B | -0.39%4.63B | 2.21%4.49B | -3.23%4.64B | 1.31%4.4B | 3.43%4.8B |
| Non-current assets | ||||||||||
| Property, plant and equipment | -24.00%19M | -20.69%23M | -24.24%25M | -17.14%29M | -2.94%33M | 6.06%35M | -2.86%34M | -15.38%33M | 0.00%35M | 21.88%39M |
| Investment property | -2.43%3.85B | -4.45%3.82B | -1.57%3.95B | -4.83%4B | -10.69%4.01B | -11.02%4.2B | -4.57%4.49B | -0.02%4.72B | 5.73%4.71B | 2.99%4.72B |
| Associated company interest | -4.35%22M | -4.35%22M | -4.17%23M | --23M | --24M | ---- | ---- | ---- | ---- | ---- |
| Interests in Joint Venture | 2.33%88M | 2.35%87M | -26.50%86M | -25.44%85M | 0.86%117M | -4.20%114M | 0.87%116M | 7.21%119M | 12.75%115M | 9.90%111M |
| Secured deposits-non-current assets | ---- | --8M | --1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Financial assets at fair value-non-current assets | 278.57%53M | 308.33%49M | 27.27%14M | 100.00%12M | 450.00%11M | 200.00%6M | --2M | --2M | ---- | ---- |
| Intangible assets | -46.15%7M | -41.18%10M | -35.00%13M | -29.17%17M | -25.93%20M | 2,300.00%24M | 800.00%27M | -75.00%1M | -40.00%3M | -42.86%4M |
| Goodwill | 0.00%18M | 0.00%18M | 0.00%18M | 0.00%18M | 0.00%18M | 100.00%18M | 100.00%18M | 0.00%9M | 0.00%9M | 28.57%9M |
| Deferred tax assets | --50M | --18M | ---- | ---- | -80.00%2M | --2M | --10M | ---- | ---- | ---- |
| Special items of non-current assets | --19M | --1M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --7M |
| Total non-current assets | -0.50%4.18B | -3.18%4.12B | -2.78%4.2B | -5.20%4.25B | -9.73%4.32B | -9.21%4.48B | -2.84%4.79B | -0.26%4.94B | 5.03%4.93B | 3.23%4.95B |
| Total assets | -9.41%8.48B | 3.21%9.46B | 6.16%9.36B | 0.63%9.17B | -5.01%8.82B | -4.94%9.11B | -0.46%9.28B | -1.72%9.58B | 3.24%9.33B | 3.33%9.75B |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Accounts payable | 2.20%2.65B | 15.07%3.06B | 16.37%2.6B | 17.02%2.66B | 12.12%2.23B | 4.07%2.27B | -2.98%1.99B | -15.08%2.19B | -5.79%2.05B | 6.59%2.57B |
| Notes payable | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.23B | --1.27B | ---- |
| Tax payable | -17.42%147M | -11.98%147M | -10.55%178M | -13.47%167M | -7.87%199M | -6.31%193M | 10.20%216M | 14.44%206M | 45.19%196M | 26.76%180M |
| Amounts payable to associated parties-current liabilities | 27.50%204M | 3.16%163M | -23.08%160M | -18.13%158M | -1.89%208M | 0.52%193M | 12.77%212M | 16.36%192M | -1.57%188M | -6.78%165M |
| Bank loans and overdrafts | -45.67%1.64B | 62.92%2.64B | 71.70%3.02B | -0.37%1.62B | 70.32%1.76B | 73.88%1.62B | -5.50%1.03B | -9.93%934M | 13.06%1.09B | 1.77%1.04B |
| Financial lease liabilities-current liabilities | -20.59%27M | 10.71%31M | 6.25%34M | -9.68%28M | 0.00%32M | 63.16%31M | 39.13%32M | -13.64%19M | 4.55%23M | 120.00%22M |
| Total current liabilities | -22.62%4.67B | 30.33%6.09B | 34.93%6.04B | 7.47%4.68B | 26.88%4.48B | -9.07%4.35B | -26.98%3.53B | 19.06%4.78B | 22.93%4.83B | -26.37%4.02B |
| Net current assets | 57.50%-374M | -410.37%-748M | -4,500.00%-880M | -12.68%241M | -97.93%20M | 297.14%276M | 323.33%967M | -117.93%-140M | -205.35%-433M | 195.59%781M |
| Total assets less current liabilities | 14.60%3.81B | -25.03%3.37B | -23.49%3.32B | -5.63%4.49B | -24.55%4.34B | -0.81%4.76B | 28.02%5.76B | -16.29%4.8B | -11.91%4.5B | 44.06%5.73B |
| Non-current liabilities | ||||||||||
| Long-term bank loan | 203.22%1.32B | -42.08%863M | -65.34%435M | 4.34%1.49B | -39.02%1.26B | 61.54%1.43B | 181.53%2.06B | 13.62%884M | 21.63%731M | 25.48%778M |
| Financial lease liabilities-non-current liabilities | -58.33%10M | -40.91%13M | -4.00%24M | -15.38%22M | -13.79%25M | 333.33%26M | 866.67%29M | -25.00%6M | -84.21%3M | 33.33%8M |
| Deferred tax liability | -2.80%243M | -6.32%237M | -3.85%250M | -6.99%253M | -14.19%260M | -12.54%272M | -1.62%303M | -3.12%311M | 6.94%308M | 2.56%321M |
| Convertible notes and bonds | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --1.26B |
| Retirement benefit responsibility | ---- | ---- | -4.29%67M | -13.00%87M | 9.38%70M | 58.73%100M | 236.84%64M | 293.75%63M | -69.35%19M | -72.41%16M |
| Total non-current liabilities | 102.58%1.57B | -39.90%1.11B | -51.80%776M | 1.42%1.85B | -34.39%1.61B | 44.46%1.83B | 131.29%2.45B | -46.91%1.26B | -54.27%1.06B | 138.82%2.38B |
| Total liabilities | -8.37%6.24B | 10.40%7.21B | 11.98%6.81B | 5.68%6.53B | 1.74%6.09B | 2.12%6.18B | 1.53%5.98B | -5.49%6.05B | -5.73%5.89B | -0.85%6.4B |
| Total assets less total liabilities | -12.21%2.24B | -14.59%2.25B | -6.81%2.55B | -10.02%2.64B | -17.23%2.73B | -17.01%2.93B | -3.87%3.3B | 5.46%3.53B | 23.38%3.44B | 12.37%3.35B |
| Total equity and non-current liabilities | 14.60%3.81B | -25.03%3.37B | -23.49%3.32B | -5.63%4.49B | -24.55%4.34B | -0.81%4.76B | 28.02%5.76B | -16.29%4.8B | -11.91%4.5B | 44.06%5.73B |
| Equity | ||||||||||
| Share capital | 0.00%373M | 0.00%373M | 0.00%373M | 0.00%373M | -0.27%373M | -0.27%373M | 0.00%374M | 0.00%374M | 0.00%374M | 0.00%374M |
| Reserve | -16.44%1.58B | -19.27%1.61B | -8.93%1.89B | -11.44%2B | -21.10%2.07B | -21.94%2.26B | -6.58%2.63B | 4.79%2.89B | 26.86%2.81B | 13.45%2.76B |
| Shareholders' Equity | -13.72%1.95B | -16.24%1.99B | -7.57%2.26B | -9.81%2.37B | -18.51%2.44B | -19.45%2.63B | -5.81%3B | 4.21%3.26B | 22.98%3.18B | 11.66%3.13B |
| Non-controlling interest | -0.35%287M | 0.00%268M | -0.35%288M | -11.84%268M | -4.62%289M | 12.59%304M | 20.72%303M | 23.29%270M | 28.72%251M | 23.73%219M |
| Total equity | -12.21%2.24B | -14.59%2.25B | -6.81%2.55B | -10.02%2.64B | -17.23%2.73B | -17.01%2.93B | -3.87%3.3B | 5.46%3.53B | 23.38%3.44B | 12.37%3.35B |
| Total equity and total liabilities | -9.41%8.48B | 3.21%9.46B | 6.16%9.36B | 0.63%9.17B | -5.01%8.82B | -4.94%9.11B | -0.46%9.28B | -1.72%9.58B | 3.24%9.33B | 3.33%9.75B |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants | -- | Deloitte Guan Huang Chen Fang Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.